Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

4(50.0%)

Phase 3

3(37.5%)

Phase 2

1(12.5%)

8Total

Phase 1(4)

Phase 3(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03343912Phase 1Completed

Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings

Role: lead

NCT03658473Phase 3Completed

Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions

Role: lead

NCT03443089Phase 1Completed

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

Role: lead

NCT03441841Phase 1Completed

Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine

Role: lead

NCT03366246Phase 3Completed

Efficacy of a Topical Anesthetic Containing Lidocaine and Prilocaine in Treatment With CO2 Fractional Laser

Role: lead

NCT03363997Phase 1Completed

Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days

Role: lead

NCT03359057Phase 3Completed

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

Role: lead

NCT03359070Phase 2Completed

Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris

Role: lead

All 8 trials loaded